GSK makes strong start to 2025 with growth in sales, profits and earnings Senza categoria GSK makes strong start to 2025 with growth in sales, profits and earnings Redazione 30 Aprile 2025 ETotal Q1 sales £7.5 billion +2% AER; +4% CER Specialty Medicines sales £2.9 billion (+17%); Respiratory, Immunology... Per saperne di più Maggiori informazioni su GSK makes strong start to 2025 with growth in sales, profits and earnings
